Alimera Sciences Inc. (ALIM)
Q2 2012 Earnings Call
August 9, 2012 4:30 PM ET
Rick Eiswirth – COO and CFO
Dan Myers – President and CEO
Adam Darity – Citi
Michael Faerm – Credit Suisse
Chris Holterhoff – Oppenheimer
Good day, ladies and gentlemen, and welcome to the Alimera Sciences Second Quarter 2012 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. (Operator Instructions) And as a reminder, this conference is being recorded.
I would now like to introduce your host for today, Mr. Rick Eiswirth, Chief Operating Officer and Chief Financial Officer. Sir, please go ahead.
Thank you. Good morning, everyone, and welcome to the Alimera Sciences’ conference call to discuss our second quarter 2012 financial results. A press release regarding these results was issued earlier this afternoon and is available on our website. On the call with me today is Dan Myers, our President, and Chief Executive Officer.
Before we begin our prepared remarks, I would like to remind you that various statements that we make during this call about the company’s future results of operations and financial position, business strategy and plans and objectives for Alimera’s future operations are considered forward-looking statements within the meaning of the federal securities laws.
Words such as anticipate, believe, estimate, expect, intend, may, plan, contemplate, predict, project, target, likely, potential, continue, will, would, should, could or the negative of those terms and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts